Skip to main content

Table 1 Descriptive statistics for age, pedometer step-counts and health related outcomes at baseline and week 12 for intervention and control group.

From: Erratum to: The effect of a pedometer-based community walking intervention "Walking for Wellbeing in the West" on physical activity levels and health outcomes: a 12-week randomized controlled trial

  Intervention Group (n = 39) Control Group (n = 40)
  Baseline Week 12 Baseline Week 12
Age (years) 47.3 (9.3) a 51.2 (7.9) a
Steps/day 6802 (3212) 9977 (4669) 6924 (3201) 7078 (2911)
PANAS positive 31.2 (6.7) 33.5 (7.4) 31.7 (6.9) 31.3 (7.6)
PANAS negative 20.1 (7.2) 19.1 (6.9) 20.2 (8.1) 18.8 (7.5)
EQ-5D tariff 0.88 (0.12) 0.89 (0.11) 0.87 (0.12) 0.89 (0.12)
EQ VAS 65.4 (18.3) 69.5 (17.8) 69.8 (19.7) 70.7 (18.6)
Height (m)b 1.66 (0.08) a 1.64 (0.08) a
Body Mass (kg)b 78.9 (15.6) 79.1 (15.2) 79.5 (18.1) 79.5 (17.8)
BMI (kg/m2)b 28.5 (4.8) 28.6 (4.8) 29.4 (6.3) 29.5 (6.2)
Waist circumference (cm)b 89.5 (12.6) 89.8 (12.7) 90.4 (14.6) 90.9 (15.6)
Hip circumference (cm)b 108.9 (8.8) 108.5 (9.7) 110.1 (12.4) 110.2 (11.8)
Waist:Hip Ratiob 0.82 (0.08) 0.83 (0.08) 0.82 (0.09) 0.82 (0.09)
% body fatb 30.7 (4.4) 31.2 (4.9) 31.8 (5.6) 32.5 (6.3)
Systolic blood pressure (mm Hg)b 118.2 (17.9) 119.2 (17.0) 119.9 (15.9) 121.4 (15.1)
Diastolic blood pressure (mm Hg)b 75.1 (11.4) 76.3 (12.2) 75.5 (11.8) 78.2 (11.8)
Heart Rate (beats.min-1)c 68.6 (7.2) 69.5 (8.3) 67.9 (8.6) 68.9 (9.0)
Total Cholesterol (mmol.l-1)c 5.4 (1.3) 5.4 (1.2) 5.5 (1.1) 5.5 (1.0)
HDL (mmol-1)c 1.3 (0.3) 1.3 (0.3) 1.4 (0.4) 1.4 (0.4)
Chol:HDL Ratioc 4.2 (1.1) 4.2 (1.1) 4.1 (1.2) 4.1 (1.3)
  1. Values are mean (M) and standard deviation (SD).
  2. a not measured at week 12
  3. b anthropometric measures: (n = 37) for intervention group, (n = 39) for control group
  4. c blood measures: (n = 32) for intervention group, (n = 34) for control group
  5. Note: there were no significant differences between the intervention and control group for any variable at baseline